Las prescripciones en diferentes países | 28 DIC 17

Utilización de drogas antiepilépticas en pediatría

Revisión sistemática sobre el uso de drogas anti epilépticas en pediatría
Autor/a: Oluwaseun Egunsola, Imti Choonara, Helen M Sammons BMJ Paediatrics Open 2017;1:e000088.
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

1. Weijenberg A, Offringa M, Brouwer OF, et al. RCTs with new antiepileptic drugs in children: a systematic review of monotherapy studies and their methodology. Epilepsy Res 2010; 91:1–9.

2. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, Lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007;369:1000–15.

3. Kimland E, Rane A, Ufer M, et al. Paediatric adverse drug reactions reported in Sweden from 1987 to 2001. Pharmacoepidemiol Drug Saf 2005;14:493–9.

4. Loke YK. Use of databases for clinical research. Arch Dis Child 2014;99:587–9.

5. Clavenna A, Bonati M. Differences in antibiotic prescribing in paediatric outpatients. Arch Dis Child 2011;96:590–5.

6. Clavenna A, Bonati M. Drug prescriptions to outpatient children: a review of the literature. Eur J Clin Pharmacol 2009;65:749–55.

7. van de Vrie-Hoekstra NW, de Vries TW, van den Berg PB, et al. Antiepileptic drug utilization in children from 1997-2005--a study from the Netherlands. Eur J Clin Pharmacol 2008;64:1013–20.

8. Hsieh LP, Huang CY. Trends in the use of antiepileptic drugs in Taiwan from 2003 to 2007: a population-based national health insurance study. Epilepsy Res 2011;96:81–8.

9. Nicholas JM, Ridsdale L, Richardson MP, et al. Trends in antiepileptic drug utilisation in UK primary care 1993-2008: cohort study using the General Practice Research Database. Seizure 2012;21:466–70.

10. Kwong KL, Tsui KW, Wu SP, et al. Utilization of antiepileptic drugs in Hong Kong children. Pediatr Neurol 2012;46:281–6.

11. Tan WW, Kong ST, Chan DW, et al. A retrospective study on the usage of antiepileptic drugs in asian children from 2000 to 2009 in the largest pediatric hospital in Singapore. Pharmacoepidemiol Drug Saf 2012;21:1074–80.

12. Pickrell WO, Lacey AS, Thomas RH, et al. Trends in the first antiepileptic drug prescribed for epilepsy between 2000 and 2010. Seizure 2014;23:77–80.

13. Landmark CJ, Fossmark H, Larsson PG, et al. Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population. Epilepsy Res 2011;95:51–9.

14. Bourgeois FT, Olson KL, Poduri A, et al. Comparison of drug utilization patterns in Observational Data: antiepileptic drugs in Pediatric Patients. Paediatr Drugs 2015;17:401–10.

15. Lee SY, Jung KY, Lee IK, et al. Prevalence of treated epilepsy in Korea based on national health insurance data. J Korean Med Sci 2012;27:285–90.

16. National Institute for Health and Clinical Excellence. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care, 2012. Available from.

17. Putignano D, Clavenna A, Campi R, et al. Antiepileptic drug use in italian children over a decade. Eur J Clin Pharmacol 2017;73:241–8.

18. Amstutz U, Shear NH, Rieder MJ, et al. Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions. Epilepsia


19. Leckband SG, Kelsoe JR, Dunnenberger HM, et al. Clinical pharmacogenetics implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing. Clin Pharmacol Ther 2013;94:324–8.

20. Yan W ZL. Utilization of antiepileptic drugs on Monotherapy and Polytherapy for Children at Shanghai in China. Int JPharmacol 2016;12:496–504.

21. Chen CB, Hsiao YH, Wu T, et al. Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians. neurology 2017;88:78–86.

22. Hung SI, Chung WH, Liu ZS, et al. Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. Pharmacogenomics



Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024